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Abstract
Gram positive bacteria produce cell envelope macroamphiphile glycopolymers, i.e. lipoteichoic acids or lipoglycans, whose
functions and biosynthesis are not yet fully understood. We report for the first time a detailed structure of lipoteichoic acid
isolated from a Streptomyces species, i.e. Streptomyces hygroscopicus subsp. hygroscopicus NRRL 2387T. Chemical, MS and
NMR analyses revealed a polyglycerolphosphate backbone substituted with a-glucosaminyl and a-N-acetyl-glucosaminyl
residues but devoid of any amino-acid substituent. This structure is very close, if not identical, to that of the wall teichoic
acid of this organism. These data not only contribute to the growing recognition that lipoteichoic acid is a cell envelope
component of Gram positive Actinobacteria but also strongly support the recently proposed hypothesis of an overlap
between the pathways of lipoteichoic acid and wall teichoic acid synthesis in these bacteria. S. hygroscopicus lipoteichoic
acid induced signalling by human innate immune receptor TLR2, confirming its role as a microbe-associated molecular
pattern. Its activity was partially dependant on TLR1, TLR6 and CD14. Moreover, it stimulated TNF-a and IL-6 production by a
human macrophage cell line to an extent similar to that of Staphylococcus aureus lipoteichoic acid. These results provide
new clues on lipoteichoic acid structure/function relationships, most particularly on the role of the polyglycerolphosphate
backbone substituents.
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Introduction
Gram positive cell envelopes are characterized by the presence
of cell-wall glycopolymers that are attached either to peptidogly-
can or to membrane lipids. Lipid-linked glycopolymers are
referred to as macroamphiphiles [1,2]. Many species contain both
types of them [3–5]. The main macroamphiphiles are lipoteichoic
acids (LTA), which are encountered in the majority of low G+C
bacteria (Firmicutes) [6,7]. LTA is composed of a lipid anchor
linked to a chain of poly-glycerol or poly-ribitol units separated by
a phosphate group. Such repeated units are also characteristic of
teichoic acids linked to peptidoglycan. In contrast, some of the
high G+C Gram positive bacteria, i.e. Actinobacteria, do not
produce LTA but rather lipoglycans [3,8–11]. Lipoglycans, of
which mycobacterial lipoarabinomannan (LAM) is the archetype
molecule [12], are macroamphiphiles made of a long chain of
mannosyl units with possible arabinose and/or mannose ramifi-
cations. They were proposed to discriminate bacteria of the
phylum Actinobacteria [3,7]. However, LTA molecules have
recently been characterized in a few number of Actinomycetes,
such as Agromyces species [13] and Thermobifida fusca [1] and several
lines of evidence suggest that Streptomyces species would also
produce LTA [14,15]. Identification of LTA in Actinobacteria
raises the question of its biosynthesis in these bacteria. Indeed, the
enzyme LtaS polymerase, which catalyses phospho-glycerol unit
polymerization and is essential for LTA synthesis in Staphylococcus
aureus, lacks clear orthologues in the sequenced actinobacterial
genomes [2]. Thus, LTA biosynthesis in Actinomycetes may
proceed by an alternative pathway and Sutcliffe and colleagues [2]
propose the attractive hypothesis that it could be achieved by a
pathway that overlaps with that of teichoic acid biosynthesis, as
suggested recently for Streptococcus pneumoniae [16].
The physiological roles of LTA are not yet fully understood.
LTA is indispensable in S. aureus, however its amount can be
reduced by 90% with only minor phenotypic changes during in
vitro cultivation [17]. It seems to play a role in cell division,
bacterial surface properties, autolysin activity and cation storage
[5,17,18]. Interestingly, LTA expression on the group B
Streptococcus surface plays a role in bacterial interaction with
blood-brain barrier endothelium and the pathogenesis of neonatal
meningitis [19]. However, the role of LTA in infection and
inflammation is somewhat controversial. For some authors, LTA
shares with LPS many of its pathogenic properties [20,21] and is
thought to be involved in infection and post infection sequelae,
such as septic shock caused by Gram-positive bacteria [20]. On
the contrary, others argue that LTA is not the dominant
immunobiologically active compound in S. aureus [22]. LTA, as
well as lipoglycans, are recognized by the innate immune system
via Toll-like receptor 2 (TLR2), a receptor that plays a crucial role
in detecting invading Gram-positive bacteria. TLR2-stimulating
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contamination of LTA fractions by highly active lipopeptides
being formally difficult to rule out [23]. However, immune
activation is induced by synthetic LTA [24] and by LTA from a
mutant S. aureus strain lacking lipoproteins [25], confirming the
role of LTA as a microbe-associated molecular patterns (MAMPs)
of Gram-positive bacteria detected by the innate immune system.
In the present study, we report for the first time a detailed
structural model of LTA isolated from a Streptomyces species. Its
capacity to induce TLR2 signaling and to stimulate cytokine
production was investigated. Altogether, our results provide new
clues on LTA biosynthesis in Actinobacteria and LTA structure/
function relationships.
Results
Extraction, purification and structural characterization of
a LTA from S. hygroscopicus NRRL 2387 (ShLTA)
Macroamphiphile glycopolymers are classically extracted by a
hot phenol-water procedure [26]. However, this might result in
partially degraded LTA and most particularly in the loss of alanine
substituents [27]. S. hygroscopicus NRRL 2387 cells were thus
extracted by the more gentle butanol procedure introduced by
Morath et al. [27]. After enzymatic degradation of the nucleic acid
and protein contaminants, the fraction was purified by hydropho-
bic interaction chromatography (HIC). This allowed removal of a
glycopolymer, eluted with 10% isopropanol, composed of
galactose and KDN (2-keto-3-deoxy-D-glycero-D-galacto-nononic
acid) previously described in Streptomyces species [28,29] and that
represented around 50% (w/w) of the fraction before HIC. SDS-
PAGE analysis of the HIC fraction eluted with 35% of isopropanol
revealed a compound with an apparent molecular weight of
around 20 kDa and a migration pattern, as a broad band, similar
to that of mycobacterial lipoglycans or LTA from S. aureus
(SaLTA) (Figure 1). Its molecular mass distribution was estimated
by MALDI-TOF mass spectrometry to be between 7 and 9 kDa
for the major molecular species (not shown). Chemical analyses of
the compound indicated a mean phosphorus content of 20 mol of
phosphorus per mol of molecule, suggesting a LTA rather than a
lipoglycan structure. Accordingly, it was recognized in ELISA
experiments by an antibody directed against Staphylococcus epidermis
LTA (Figure 2). This antibody also recognized SaLTA but
neither mycobacterial lipoglycans nor the synthetic lipopeptide
Pam3CSK4. In addition, glycerol (Gro) and glycerol-phosphate
(Gro-P) were detected by gas chromatography (GC)/MS suggest-
ing a polyglycerolphosphate LTA (PGP-LTA). The compound
was subsequently termed ShLTA. The predominant fatty acids
detected by GC after alkaline hydrolysis were C16:0 (40%), isoC16
(11%), isoC17:0 (13%), anteisoC17:0 (28%), isoC15:0 (2%) and
anteisoC15:0 (4%), a profile typical of Streptomyces species whole
cells [30]. Glucosamine (GlcN) but neither mannosamine nor
galactosamine were detected by GC and capillary electrophoresis
monitored by laser-induced fluorescence (CE-LIF) after strong
acid hydrolysis of ShLTA. Quantitative analyses by colorimetric
assays indicated a ratio GlcN/phosphorus of 0.28/1 (mol:mol)
(Table 1). No release of amino acids (,0.1% w/w), after acid
hydrolysis, could be detected by a highly sensitive approach based
on liquid chromatography (LC) monitored by LIF [31], indicating
that ShLTA is neither substituted by amino acids nor contami-
nated by traces amount of lipopeptides.
To get further insights into the distribution of the different
structural motifs along the molecule backbone, ShLTA was
submitted to 48% hydrofluoric acid (HF) hydrolysis for 48 h at
4uC, a reaction known to hydrolyze phosphodiester bonds. After a
chloroform/methanol/water partition, the aqueous phase was
analyzed by MALDI-TOF/MS and MS/MS. The data are
summarized in Table 2. HF treatment did not completely
hydrolyse all the phosphodiester bonds. Indeed, the positive
MALDI mass spectrum showed peaks at m/z 254.1, 336.1, 408.1,
569.2 and 611.2 attributed to (M+H)
+ molecular ions that could be
assigned to structures containing the motifs Gro-GlcN, P-Gro-
GlcN, Gro-P-Gro-GlcN, Gro-GlcN-P-Gro-GlcN, and Gro-
GlcNAc-P-Gro-GlcN respectively (Table 2). The assignments
were confirmed by MS/MS analysis showing fragment ions
characteristic of the loss of an amino sugar (i.e. GlcN) at m/z 162.0
or a N-acetylated amino sugar (i.e. GlcNAc: N-acetyl-glucosamine)
at m/z 204.0 [32] (Table 2). Interestingly, the molecular ion at m/z
611.2 corresponded to a fragment containing both N-acetylated
and non-N-acetylated amino sugars, suggesting that the PGP
Figure 1. SDS-PAGE analysis of a macroamphiphile glycopoly-
mer from S. hygroscopicus. Lane 1, Mycobactrium tuberculosis LAM
and LM (top and bottom bands, respectively); lane 2, S. hygroscopicus
macroamphiphile glycopolymer; lane 3, S. aureus LTA. The gel was
revealed by periodic acid-silver nitrate staining. LAM, lipoarabinoman-
nan; LM, lipomannan; LTA, lipoteichoic acid.
doi:10.1371/journal.pone.0026316.g001
Figure 2. An anti-LTA antibody recognizes S. hygroscopicus
macroamphiphile glycopolymer. 100 ng of S. hygroscopicus or S.
coelicolor macroamphiphile glycopolymers (ShLTA and ScLTA, respec-
tively), S. aureus LTA (SaLTA), Pam3CSK4 synthetic lipopeptide or M.
tuberculosis lipoglycans mixture were coated in microtiter plate wells
and probed with an antibody directed against S. epidermis LTA (anti-
LTA). The results are mean 6 SD and are representative of three
separate experiments.
doi:10.1371/journal.pone.0026316.g002
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sugars. The control that a GlcNAc standard was not hydrolyzed
into GlcN by HF treatment supported the above hypothesis.
Native ShLTA was subsequently analyzed by NMR. The
1H-
NMR anomeric region exhibited two anomeric signals at d 5.43
(GI1) and d 5.10 (GII1) in a ratio 3.7/1 (Figure 3D), tentatively
attributed to both types of glucosamines (i.e. GlcN and GlcNAc).
As revealed by
1H-
13C HMQC spectrum, their corresponding
anomeric carbons resonate at d 96.0 (GI1) and d 98.3 (GII1)
(Figure 3F). Proton and carbon resonances of both spin sys-
tems were assigned from
1H-
13C HMQC and
1H-
1H HOHAHA
experiments (partially shown in Figures 3F, 3G and 3E,
respectively). The assignments are summarized in Table 3. The
chemical shift of C2 in both spin systems around 55 ppm was
typical of amino sugars and the
1JC1,H1 coupling constant of
174 Hz indicated an a-anomeric configuration for both units. H2
resonances at d 3.36 (GI2) and d 3.94 (GII2) (Figure 3E) were
indicative of a non-N-acetylated and an N-acetylated glucosamine,
respectively [33]. This was confirmed by a NOESY experiment
recorded with ShLTA dissolved in H2O/D2O (9:1, v/v)
(Figures 3B and C). Indeed, an amide proton at d 8.21 (GIINH)
(Figure 3A) showed intracyclic correlations with different protons
that belonged to spin system GII (Figure 3C). In addition, another
correlation was observed with methyl protons of an N-acetyl group
at 2.09 ppm (Figure 3B). Altogether the data indicated that GI and
GII spin systems correspond to a-GlcN and a-GlcNAc, respec-
tively. Another amide proton resonance at d 8.29 (GIIINH) with
very low intensity (,10%) was also observed and most probably
corresponded to a minor form of N-acetylated amino sugar, whose
characterization could not be carried out further.
Interestingly, nOe contacts were observed between anomeric
protons of GI and GII and methine protons at d 4.19 (gIII2) and d
4.05 (gIV2) respectively (Figure 3H), attributed to H2 protons of
1,3-diphospho-glycerol (P-1-Gro-3-P) units (Table 3) [33]. These
data indicated that GlcN and GlcNAc units were a-glycosidically
linked to the C2 hydroxyl of the PGP repeating units. This was
confirmed by an additional correlation on the NOESY spectrum
between amide proton GIINH at d 8.21 and proton gIV2
(Figure 3D) and by HMBC experiment showing connectivities
between anomeric protons of GI and GII and C2 of gIII and gIV
units at d 77.0 (gIII2) and d 77.3 (gIV2) respectively (not shown)
(Table 3). The deshielding of the C2 resonances of these units
(gIII2 and gIV2) as compared with C2 resonance of an
unsubstituted P-1-Gro-3-P unit at d 70.8 (gI2)( Dd 6.2 and
6.5 ppm, respectively) (Figure 3G; Table 3) was also in agreement
with their substitution by glycosyl units. In contrast, C2 of Gro unit
gII (gII2), whose resonance at d 76.6 was also deshielded as
compared to that of gI (Dd 5.8 ppm) (Figure 3G; Table 3), did not
show in the HMBC experiment any correlation with protons,
except with those of its own spin system (not shown). Similarly, H2
of gII unit did not correlate in NOESY or ROESY experiments
with any protons other than those of its own spin system. Although
clearly not glycosylated, the deshielding of C2 resonance indicated
that this position was substituted and we hypothesized that gII spin
system corresponded to 2,3-diphospho-glycerol (2-P-Gro-3-P)
Table 1. Relative abundance of phosphorus, glycerol and
glucosamines in S. hygroscopicus LTA as determined by
biochemical and NMR analyses.
Biochemical
a NMR
b
P1 -
Gro: 1.7 1:
(P-1-Gro-3-P) (0.50)
(P-1-Gro-3-P) (0.22)
c
|
GlcN
(P-1-Gro-3-P) (0.06)
c
|
GlcNAc
(P-2-Gro-3-P) (0.22)
GlcN+GlcNAc 0.28 0.28
aRelative quantification of P and amino sugars (i.e. GlcN+GlcNAc) was
performed by colorimetric assays, the amount of P being fixed to 1. The ratio
Gro/amino sugars was determined by GC but is overestimated because of
partial amino sugar degradation during strong acid hydrolysis.
bRelative quantification of the different Gro derivatives was performed by
integration of the corresponding H-2/C-2 cross peak on
1H-
13C HMQC
spectrum (Figure 3G).
cThese values perfectly fit with the GlcN/GlcNAc ratio of 3.7/1 as determined by
integration of the corresponding anomeric signals (Figure 3D).
Gro, glycerol; GlcNAc, N-acetyl-glucosamine; GlcN, glucosamine; P, phosphate;
P-1-Gro-3-P, P-2-Gro-3-P, 1,3- and 2,3-diphospho-glycerol units respectively.
doi:10.1371/journal.pone.0026316.t001
Table 2. Positive ion MALDI-TOF/MS and MS/MS analyses of structural motifs generated by HF hydrolysis (48%, 48 h at 4uC) of
ShLTA.
MS Parent ions m/z
(relative intensity) MS/MS Fragments ions m/z Composition M Molecular formula M
162.0 (M
+) (1) - Anhydro-GlcN C6H12O4N
204.0 (M
+) (0.21) - Anhydro-GlcNAc C7H14O5N
254.1 (M+H
+) (0.97) 162 Gro-GlcN C9H19O7N
336.1 (M+H
+) (0.11) 162 P-Gro-GlcN C9H22O10NP
408.1 (M+H
+) (0.28) 162, 247
a Gro-P-Gro-GlcN C12H26O12NP
569.2 (M+H
+) (0.15) 162, 247
a Gro-GlcN-P-Gro-GlcN C18H37O16N2P
611.2 (M+H
+) (0.14) 162, 204, 408, 450
a Gro-GlcNAc-P-Gro-GlcN C20H39O17N2P
m/z of parent and fragment ions, possible composition and Molecular formula are shown. Gro, glycerol; GlcNAc, N-acetyl-glucosamine; GlcN, glucosamine; P, phosphate
group.
aloss of GlcN.
doi:10.1371/journal.pone.0026316.t002
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31P
NMR analysis of deacylated ShLTA. Indeed, on
1H-
31P HMQC
spectrum, a phosphate resonance at 2.3 ppm correlated with H2
of gII unit at 4.33 ppm (not shown), indicating that the C2
hydroxyl of gII was directly substituted by a phosphate group.
Integration of the Gro unit H2-C2 cross-peaks on HMQC
experiment (Figure 3G) allowed us to obtain the relative
proportion of the different motifs on the PGP chain (Table 1)
and propose the structural model depicted in Figure 4.
TLR2 activation and cytokine production
LTA has been reported to activate phagocytic cells via
recognition by TLR2 and TLR6 [35–38]. The molecular bases
of this recognition have been recently partially uncovered by the
resolution of a crystal structure of a soluble form of TLR2 in
complex with S. pneumonia LTA [39]. We first tested the ability of
ShLTA to stimulate HEK293 cells stably transfected with human
TLR2 and CD14 genes and a NF-kB-inducible reporter system
(HEK-TLR2 cells). As expected, ShLTA induced NF-kB activa-
tion in HEK-TLR2 cells (Figure 5) but not in the parent HEK cells
(not shown). ShLTA stimulatory activity was inhibited by the anti-
LTA antibody (Figure 5A). The latter did not show any effect on
activation by the TLR2 ligands Pam3CSK4 (Figure 5A) or FSL-1
(not shown), strongly suggesting that ShLTA activity was not due
to contaminating lipopeptides. However, in agreement with a
recent report by Seo et al. [40], ShLTA activity was altered by
treatment by H2O2 (Figure 6A) or by a lipoprotein lipase
(Figure 6B). Indeed, although previously thought to be selective
of lipopeptide/lipoproteins [22,23], these treatments have been
recently shown to also affect the chemical structure of pneumo-
coccal and staphylococcal LTA [40]. The requirement of TLR1 or
TLR6 for recognition of ShLTA by TLR2 was tested using
blocking antibodies. Whereas the activity of the triacylated
Pam3CSK4 and diacylated FSL-1 lipopeptides was clearly
dependant on TLR1 and TLR6 respectively, activity of ShLTA
was partially inhibited by both anti-TLR1 and anti-TLR6
antibodies (Figure 5B). ShLTA activity was also dependant on
CD14 (Figure 5C). Finally, we investigated the capacity of ShLTA
to activate the human THP-1 monocyte/macrophage cells, using
a cell line derivative that stably expresses a NF-kB-inducible
reporter system. ShLTA induced NF-kB activation (Figure 7A)
and IL-6 (Figure 7B) and TNF-a (Figure 7C) production by these
cells to an extent similar to that of SaLTA.
Discussion
In the present study, we report the first detailed structure of a
LTA isolated from a Streptomyces species, i.e. S. hygroscopicus, and so
confirms the presence of LTA in Streptomyces as previously
suggested [14,15]. The assumption that LTA was absent from
Actinomycetes most probably resulted from a sampling bias, since
essentially families from the suborder Corynebacterineae, that all
contain lipoglycans, have been analyzed so far [1]. In agreement
with a preliminary report by Rahman et al. [15], we also isolated
LTA in Streptomyces coelicolor (ScLTA). It was recognized by the anti-
LTA antibody (Figure 2) and preliminary structural analyses
indicated that this LTA, as ShLTA, was of PGP type. However,
surprisingly, we could not detect any macroamphiphile glycopo-
Figure 3. 1D
1H (A, D), 2D
1H-
13C HMQC (F, G),
1H-
1H HOHOHA tm 110 ms (E) and
1H-
1H NOESY tm 500 ms (B, C, H) spectra of ShLTA.
1H (D),
1H-
13C HMQC,
1H-
1H HOHOHA and
1H-
1H NOESY (H) were recorded in D2O,
1H (A) and
1H-
1H NOESY (B, C) in H2O/D2O (9:1) at 298K. Expanded
regions (d
1H: 8.10–8.40) (A), (d
1H: 8.10–8.40, d
1H: 2.00–2.30) (B), (d
1H: 8.10–8.40, d
1H: 3.20–5.70) (C), (d
1H: 5.05–5.50) (D), (d
1H: 5.05–5.50, d
1H: 3.20–
5.70) (E), (d
1H: 5.05–5.50, d
13C: 95–100) (F), (d
1H: 3.90–4.40, d
13C: 65–80) (G) and (d
1H: 3.90–4.40, d
1H: 3.20–5.70) (H) are shown. GI, a-GlcN, GII, a-
GlcNAc, gI to gIV, Gro units (see Table 3 and Figure 4). GIII corresponds to a weakly abundant GlcNAc that could not be further characterized.
doi:10.1371/journal.pone.0026316.g003
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apparent absence of macroamphiphiles in the thermophilic
Actinomycete Rubrobacter xylanophylus [1]. Our data thus extend
their observation and demonstrate that within a given genus, some
Table 3. Proton and carbon chemical shifts of S.
hygroscopicus LTA.
Residue Name Protons d (ppm) Carbons d (ppm)
P-1)-Gro-(3-P- gI H-1, H-19 3.98/3.91 C-1 67.5
H-2 4.06 C-2 70.8
H-3, H-39 3.98/3.91 C-3 67.5
P-2)-Gro-(3-P- gII H-1, H-19 4.05 C-1 66.8
H-2 4.33 C-2 76.6
H-3, H-39 3.78/3.81 C-3 62.2
P-1)-Gro-(3-P-2) gIII H-1, H-19 4.04/4.13 C-1 66.0
H-2 4.19 C-2 77.0
| H-3, H-39 4.04/4.13 C-3 66.0
a-GlcN GI H-1 5.43 C-1 96.0
a
H-2 3.36 C-2 55.3
H-3 3.97 C-3 71.1
H-4 3.50 C-4 70.9
H-5 3.96 C-5 73.7
H-6, H-69 3.91/3.81 C-6 61.7
P-1)-Gro-(3-P-2) gIV H-1, H-19 3.98 C-1 67.5
H-2 4.05 C-2 77.3
| H-3, H-39 3.90 C-3 67.5
a-GlcNAc GII H-1 5.10 C-1 98.3
a
H-2 3.94 C-2 55.0
b
H-3 3.82 C-3 72.4
H-4 3.50 C-4 70.9
H-5 3.97 C-5 73.7
H-6, H-69 3.91/3.81 C-6 61.7
Chemical shifts were measured at 298K in D2O and are referenced relative to
internal acetone signals at dH 2.225 and dC 34.00. Gro, glycerol; GlcNAc, N-
acetyl-glucosamine; GlcN, glucosamine; P, phosphate; P-1-Gro-3-P, P-2-Gro-3-P,
1,3- and 2,3-diphospho-glycerol units respectively.
a1JH-1,C-1=174 Hz.
bCH3CONH at 2.09 ppm and CH3CONH at 8.21 ppm.
doi:10.1371/journal.pone.0026316.t003
Figure 4. Proposed structure of ShLTA. The PGP backbone is
shown, with n, m, p and q estimated to be ca. 10, 4, 1 and 4
respectively. The relative position of the different motifs along the
backbone is unknown. The LTA lipid anchor, presumptively a glycosyl-
containing diacylglyceride glycolipid, is not shown. GI, GII and gI to gIV
refer to spin systems as defined in Figure 3 and Table 3.
doi:10.1371/journal.pone.0026316.g004
Figure 5. ShLTA activity is inhibited by an anti-LTA antibody
and is dependent on TLR1, TLR6 and CD14. A. Stimuli were pre-
incubated for 30 min at 37uC with 5 mg.ml
21 of anti-LTA or an IgG1
isotype control before HEK-TLR2 cells addition. ShLTA, Pam3CSK4 and M.
tuberculosis lipoglycans were tested at a concentration of 10 ng.ml
21.B ,
C. HEK-TLR2 cells were pre-incubated for 30 min at 37uC, before stimuli
addition, with 5 mg.ml
21 of various monoclonal antibodies: anti-TLR1
and anti-TLR6 (B), anti-CD14 (C) or IgG1 isotype control. ShLTA was
tested at a concentration of 10 ng.ml
21. Pam3CSK4 (5 ng.ml
21) and FSL-
1 (0.5 ng.ml
21) were used as positive controls of TLR2/TLR1 and TLR2/
TLR6 agonists, respectively. NF-kB activation was determined by
reading OD at 630 nm. The results are mean 6 SD and are
representative of three separate experiments. *, P,0.05; **, P,0.01;
***, P,0.001; ns, not significant.
doi:10.1371/journal.pone.0026316.g005
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not been reported so far in lipoglycan-containing genera.
ShLTA was found to contain a PGP backbone, composed of
78% of 1-P-Gro-3-P and 22% of 2-P-Gro-3-P repeating units. A
portion of the 1-P-Gro-3-P units were a-glycosylated at position 2
by GlcN or GlcNAc (Figure 4). Not unexpectedly, ShLTA was
devoid of D-Alanine substituents found in many PGP-LTA.
Indeed, this result is consistent with the fact that the genomes of
Actinobacteria, including Streptomyces spp., lack orthologues of the
dlt system, which is dedicated to incorporation of D-Alanine into
PGP-LTA and teichoic acids [1]. Interestingly, the PGP structure
of shLTA is very similar, apart for lacking O-acetylation, to that of
the S. hygroscopicus strain ISP 5578 (=NRRL 2387T) wall teichoic
acid previously described by Tul’skaia et al. [34]. This contrasts
with many Firmicutes, such as S. aureus or B. subtilis, for which
LTA and teichoic acids have unrelated structures and are
synthesized by two distinct pathways [3,41]. The genomes of
Actinobacteria sequenced so far (including S. coelicolor and other
Streptomyces spp) and of a few Firmicutes, such as S. pneumoniae, lack
clear orthologues of the gene encoding LtaS polymerase [1]. This
enzyme catalyses phospho-glycerol unit polymerization of LTA
and is essential for its synthesis in S. aureus. Consequently, it has
been suggested that in S. pneumoniae, LTA synthesis could be
achieved by an alternative pathway that overlaps with that of
teichoic acid biosynthesis [16,42] and Sutcliffe and colleagues [1]
propose the attractive hypothesis that this pathway could also take
place in Actinomycetes. Our finding that PGP moieties of S.
hygroscopicus LTA and teichoic acid have a very similar structure
further reinforces this hypothesis in which a PGP structure
common to both molecules could be synthesized by the same
enzymatic machinery and then transferred to peptidoglycan as
teichoic acid or to a lipid anchor to yield the PGP-LTA.
Accordingly, orthologues of the B. subtilis tagB/tagF teichoic acid
biosynthesis genes are present in the genome of S. himastatinicus (a
genome sequenced member of the S. hygroscopicus phylogenetic
subclade) and other Streptomyces spp. (data not shown), supporting
the occurrence of a pathway for teichoic acid biosynthesis in these
species.
LTA is a powerful Gram-positive immunostimulatory compo-
nent that induces cytokine production via binding to TLR2 on
phagocytic cells [43]. The structure/function relationships of this
activity are not yet fully understood and possible contamination
of LTA fractions by highly stimulatory lipoproteins have been
advanced in the literature [44]. However, we found that TLR2
Figure 6. H2O2 (A) or lipoprotein lipase (B) treatments alter
ShLTA capacity to stimulate TLR2. HEK-TLR2 cells were stimulated
with 10 ng.ml
21 ShLTA or M. smegmatis lipoproteins (MsLP) previously
treated or not with 1% H2O2 for 24 h at 37uC (A) or with Pseudomonas
sp. lipoprotein lipase (B). NF-kB activation was determined by reading
OD at 630 nm. The results are mean 6 SD and are representative of
three separate experiments. *, P,0.05; **, P,0.01; ***, P,0.001.
doi:10.1371/journal.pone.0026316.g006
Figure 7. ShLTA stimulates NF-kB activation (A) and IL-6 (B)
and TNF-a (C) production by human THP-1 monocyte/macro-
phage cell line. A. THP-1 cells were stimulated with 1 or 10 mg.ml
21 of
ShLTA, SaLTA or Pam3CSK4. NF-kB activation was determined by
reading OD at 630 nm. B, C. THP-1 cells were differentiated with
20 ng.ml
21 of PMA for 24 h and then stimulated with 1 or 10 mg.ml
21
of ShLTA, SaLTA or Pam3CSK4. IL-6 and TNF-a were assayed in the
supernatant by sandwich ELISA. The results are mean 6 SD and are
representative of three separate experiments.
doi:10.1371/journal.pone.0026316.g007
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that had no effect on synthetic lipopeptide activity. Moreover, we
failed to detect any amino acids (,0.1% w/w) in the ShLTA
fraction used for bioassays, even by the use of a very sensitive
technique based on LC-LIF [31]. Altogether, these data suggest
that ShLTA is a bona fide TLR2 ligand and they are in agreement
with the demonstration by Morath et al. [24] that synthetic LTA
is a potent stimulus of cytokine release. However, in contrast to
the proposal by the same authors [24,27], our data demonstrate
that D-alanination is not critical for LTA activity, or at least can
be replaced. Indeed, ShLTA, although devoid of D-alanine
substituents showed an activity similar to that of SaLTA. The role
played by D-alanine in SaLTA activity is not clear. One
hypothesis proposed [35] is that they could enable ionic
interactions between LTA molecules forming multimers. If this
is right, we can imagine that GlcN, rather uncommon in
prokaryotes in its non-N-acetylated form, as a positively charged
substituent, could functionally replace D-alanine in ShLTA.
However, it is worth noting that only 22% of the PGP repeating
units are substituted by GlcN in ShLTA as compared to 70% by
D-alanine in SaLTA [27]. GlcNAc is supposed to have no impact
on LTA activity [35]. ShLTA activity was altered by digestion
with a lipoprotein lipase, which has been shown to deacylate not
only lipoproteins but also LTA [40]. This observation is in
agreement with the critical role played by fatty acids for LTA
binding to TLR2 [39]. In agreement with a recent report by Seo
et al. [40], ShLTA activity was also altered by treatment with
H2O2. In contrast to what was previously thought, H2O2 and
lipoprotein lipase treatments are not selective at all of lipopep-
tide/lipoproteins [22,23] and cannot be invoked to implicate the
latter in TLR2 stimulating activities.
Using blocking antibodies experiments, we found ShLTA
activity to be dependent on CD14 and partially on TLR6 and
TLR1. Interestingly, these data are in agreement with the recent
study by Bunk et al. [25] demonstrating the required expression of
TLR6 and CD14 for HEK-TLR2 cells activation by SaLTA
devoid of lipopeptide contaminants. The choice of the TLR2
heterodimer, with either TLR1 or TLR6, can be dictated by
subtle changes in the structure of the TLR2 ligand polar head [39]
and is not yet completely understood.
Altogether, our findings contribute to the growing recognition
that LTA is a cell envelope component of Gram-positive
Actinobacteria [1]. Moreover, the detailed structure of ShLTA
PGP moiety strongly supports the hypothesis of an overlap
between the pathways of LTA and teichoic acid synthesis in
Streptomyces. However, this has now to be definitely proved by
genetic manipulation. Finally, our results provide new clues on
LTA structure/function relationships, most particularly on the
role of PGP substituents.
Materials and Methods
Srains and growth conditions
S. hygroscopicus subsp. hygroscopicus NRRL 2387 (ATCC27438), S.
coelicolor M145 and S. verticillus ATCC 21 890 II6-3 were grown at
27uC for 40 to 50 h under shaking in a culture medium which
contained 5 g of yeast extract (BioSpringer), 5 g of bacto soytone
peptone (Difco) and 20 g of glucose syrup (Roquette) per liter of
deionized water.
Extraction and purification of LTA
Cells were delipidated at 50uC by mixing with chloroform/
methanol (1:2 and then 1:1) overnight. After lyophilisation,
delipidated cells were resuspended in a 0.1 M citrate buffer
pH 4.7 and disrupted by sonication. The lysate was then extracted
twice with 1 volume of butan-1-ol. Aqueous phase, containing
LTA, was treated with DNAse, RNAse, a-amylase, pronase, a-
chymotrypsin and trypsin. After ultrafiltration, samples were
purified by hydrophobic interaction chromatography on an
octylsepharose CL-4B column eluted with increasing concentra-
tions of isopropanol (10, 15, 20, 25, 35, 40 and 80%) in 0.1 M
ammonium acetate. Fractions were collected and analyzed by
SDS-PAGE followed by periodic acid-silver nitrate staining. After
dialysis and drying, they were submitted to a water/butan-1-ol (1:1
v/v) partition. The water phases were lyophilized and stored at
220uC. The fraction eluted with 35% isopropanol was used for
further analysis.
H2O2 and lipoprotein lipase treatments
20 mg of LTA or lipoproteins (lipoproteins were extracted from
a cleared lysate of Mycobacterium smegmatis by a phenol/water
partition as previously described [45]) were resuspended in 100 ml
of 1% H2O2 and incubated at 37uC for 24 h. H2O2 was
evaporated by lyophilisation.
Lipoprotein lipase from Pseudomonas sp. (Fluka) was used at a
ratio enzyme/LTA or lipoproteins 1:2 (w/w) in a 100 mM sodium
phosphate buffer, 150 mM NaCl, 0.1% Triton X-100, pH 7.2 and
incubated for 16 h at 37uC.
Elisa assay
ShLTA, ScLTA, commercial SaLTA (InvivoGen), M. tuberculosis
lipoglycan mixture [12,46] or Pam3CSK4 (InvivoGen) (100 ng/
50 ml of ethanol/water 1:1, v/v) were adsorbed in 96-wells
microtiter plate by air drying and extensively rinsed with washing
buffer (TBS, 0.5% BSA, 0.01% Tween 20). Wells were blocked for
2 h at room temperature with TBS, 5% BSA. After washing,
100 mlo f5mg.ml
21 anti-LTA (Abcam, Ab12248) or IgG1 isotype
control (eBioscience) antibodies in TBS, 1% BSA were added for
2 h at room temperature. After washing, 100 ml of an HRP-
conjugated goat anti-mouse antibody 1/3000 (Sigma) was added
in TBS, 1% BSA for 1.5 h at room temperature. HRP activity was
detected by addition of 100 ml of Sure Blue TMB substrate (BD
Biosciences).
Chemical analyses
Phosphorus content was determined after treatment of 50 mg
LTA by 260 ml of perchloric acid at 170uC for 20 min. Then,
400 ml of freshly prepared solutions of 1.25% molybdate and 5%
ascorbate were added. After 5 min boiling in a water bath,
samples were cooled in ice. Absorbance was read at 660 nm and
phosphorus concentration was calculated relatively to a Na2HPO4
standard solution.
Amino sugars were analyzed after hydrolysis of 10 mg LTA by
6N HCl at 110uC, overnight. They were detected either by CE-
LIF using a 20 mM sodium borate buffer [47] after re-N-
acetylation [48] and APTS derivatization [47] or by GC after
trimethylsilylation by N,O-bis(trimethylsilyl)trifluoroacetamide/
trimethylchlorosilane (99:1, v/v) in pyridine (1:1, v/v) for 1 h at
110uC.
Amino sugars were quantified spectrophotometrically after
hydrolysis of 200 mg LTA as described above. HCl was evaporated
by a nitrogen stream and sample was dissolved in 250 ml of water.
Then, 500 ml of a solution of 0.625 M sodium carbonate/
acetylacetone (48:2, v/v) were added. After 10 min boiling in a
water bath, the solution was cooled and 2.5 ml of 95% ethanol
were added. After 5 min at 75uC, 500 ml of 5.3% p-dimethylami-
nobenzaldehyde in 37% HCl were added and the solution was
incubated again for 30 min at 75uC. 2.5 ml of 95% ethanol were
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sugar concentration was calculated relatively to a GlcN standard
solution.
Amino acids were analyzed after hydrolysis of 100 mg LTA by
6N HCl at 110uC, overnight by LC-LIF according to the method
described by Siri et al. [31].
Fatty acids were analyzed by GC as their methyl esters after
alkaline hydrolysis of 100 mg LTA in 1N NaOH for 2 h at 37uC.
MALDI/MS
LTA molecular mass was determined on a Voyager DE-STR
MALDI-TOF instrument (PerSeptive Biosystems) using linear
mode detection. The matrix used was 2,5-dihydroxybenzoic acid
(Sigma) at a concentration of 10 mg.ml
21 in a mixture of ethanol/
water (1:1, v/v). 0.5 ml of ShLTA, at a concentration of
10 mg.ml
21, were mixed with 0.5 ml of the matrix solution. Mass
spectra were recorded in the negative mode using a 350-ns time
delay with a grid voltage of 90% of full accelerating voltage
(25 kV) and a guide wire voltage of 0.15%.
ShLTA (1 mg) was depolymerized by 48% HF hydrolysis, 48 h
at 4uC. After drying under a nitrogen stream, the sample was
submitted to a methanol/chloroform/water (1:2:3, v/v/v) parti-
tion. Aqueous phase, containing glycerophosphate motifs, was
analyzed by MALDI/MS and MS/MS on a 4700 Proteomics
Analyzer (with TOF/TOF optics, Applied Biosystems, Voyager
DE-STR) using the reflectron mode. The matrix used was 2,5-
dihydroxybenzoic acid at a concentration of 10 mg.ml
21 in a
mixture of ethanol/water (1:1, v/v), 0.1% TFA. 0.3 ml of the
aqueous phase, at a concentration of 10 mg.ml
21, were mixed with
0.3 ml of the matrix solution. Mass spectra were recorded in the
positive mode. Collision-induced dissociation gas type was
atmosphere, and the gas pressure was set to medium.
NMR
NMR spectra were recorded with an Avance DMX500
spectrometer (Bruker) equipped with an Origin 200 SGI using
Xwinnmx 2.6. ShLTA was dissolved in D2Oo rH 2O/D2O (9:1,
v/v) (D, 99.97%, Eurisotop) and analyzed in 20065 mm 535-PP
NMR tubes at 298 K. Proton and carbon chemical shifts are
expressed in parts per million and referenced relative to internal
acetone signals at dH 2.225 and dC 34.00 ppm respectively. All
details concerning correlation spectroscopy and homonuclear
Hartmann-Hahn spectroscopy sequences used and experimental
procedures were as previously described [46].
HEK-TLR2 experiments
The HEK-Blue-2 cell line (InvivoGen), a derivative of HEK293
cells that stably expresses the human TLR2 and CD14 genes along
with a NF-kB-inducible reporter system (secreted alkaline
phosphatase) was used according to the manufacturer’s instruc-
tion. Cells were plated at 5610
4 cells per well in 96-wells plates
and the different stimuli were added at concentrations indicated in
the figure legends in the HEK-Blue Detection medium (Invivo-
Gen) that contains a substrate for alkaline phosphatase. Alkaline
phosphatase activity was measured after 18 h by reading O.D. at
630 nm. To investigate the CD14 and TLR dependence of stimuli
activity, HEK-TLR2 cells were pre-incubated for 30 min at 37uC,
before stimuli addition, with various antibodies: 5 mg.ml
21 of
monoclonal anti-CD14 (clone 134620, R&D Systems), monoclo-
nal anti-TLR1 (Clone H2G2, InvivoGen), monoclonal anti-
TLR6 (Clone C5C8, InvivoGen) or an IgG1 isotype control
(eBioscience). Anti-LTA (Abcam, Ab12248) antibody was used at a
concentration of 5 mg.ml
21 and pre-incubated with the different
stimuli for 30 min at 37uC before HEK-TLR2 cells addition.
Pam3CSK4 and FSL-1 were purchased from InvivoGen.
THP1 experiments
THP-1-Blue cell line (InvivoGen), a derivative of THP-1
monocyte/macrophage human cells that stably expresses a NF-
kB-inducible reporter system (secreted alkaline phosphatase) was
used according to the manufacturer’s instructions. Cells were
added at 10
5 cells per well in 96-wells plates in the HEK-Blue
Detection medium (InvivoGen) or differentiated with 20 ng.ml
21
of PMA for 24 h in RPMI 1640 medium (Lonza) and the different
stimuli were added at concentrations indicated in the figure
legends. NF-kB activation was measured as described above. IL-6
and TNF-a were assayed in the supernatant by sandwich ELISA
using commercially available kits (Diaclone).
Statistical analysis
Results are expressed as a mean 6 SD and were analyzed using
the Student’s t test to determine significant differences between
samples.
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